FLT3-ITD mutation analysis

FLT3-ITD mutation analysis
Lab Test name Contact Comments
IPG Gosselies FLT3-ITD mutation analysis
AZ St-Jan Brugge - Laboratoriumgeneeskunde FLT3-ITD mutation analysis dr. Helena Devos/Friedel Nollet, Ph.D.
At diagnosis : DNA test, PCR and capillary electrophoresis. Multiplex assay with NPM1 and CEBPalpha mutation analysis. Consensus primers from working group MolecularDiagnostics.be.
Version date: 04/11/2017
Accredited:
CHU Li├Ęge - Hemato FLT3-ITD mutation analysis Pr V. Bours
Not done due to FLT3-ITD patenting.
Please request the test directly to the patent holder.
Jessa Hospital FLT3-ITD mutation analysis Dr. Brigitte Maes, Femke Hillen
SAMPLE TYPE:
Blood or bone marrow (1ml, EDTA)
TRANSPORT: room temperature
FREQUENCY: 1x/week
TEST TYPE: Only at diagnosis or relapse: DNA test, PCR and capillary electrophoresis. Multiplex assay with NPM1 mutation analysis. Consensus primers from working group MolecularDiagnostics.be.
UZ Leuven MolPLUZ FLT3-ITD mutation analysis Lucienne Michaux / Els Lierman
Sample type: blood / bone marrow (EDTA, 2-5 ml)
Frequency: 2x/week
Test type: PCR on DNA, adapted from Noguera et al, Leukemia 2008.
Accredited:
AZ Delta FLT3-ITD mutation analysis Geert Martens, Elke Boone
SAMPLE TYPE: blood or bone marrow (1 ml)
FREQUENCY: upon request, at diagnosis or relapse
TEST TYPE: DNA test, PCR and capillary electrophoresis. Multiplex assay with CEBPA and NPM1 mutation analysis. Consensus primers from working group MolecularDiagnostics.be.
Version date: 05/12/2017
Accredited: